Oncotelic Therapeutics (OTLC) Current Assets (2010 - 2026)
Oncotelic Therapeutics (OTLC) recorded Current Assets of $1.46 million in Q2 2026, up 961.6% from $137,592 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Oncotelic Therapeutics reported Current Assets of $1.2 million, up 792.8% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of 14.2% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $134,211 in FY2024 (-50.6%), $271,737 in FY2023 (-10.4%), $303,164 in FY2022 (-51.7%) and $627,295 in FY2021 (+1.9%).
- Quarterly Current Assets has ranged from $124,993 in Q1 2025 to $1.61 million in Q3 2025 over the past five years.
- On a year-over-year basis, Current Assets rose in three of the last seven quarters, with growth averaging 310.0%.
- Peak year-over-year performance for Current Assets in the last five years was growth of 961.6% in Q2 2026, against a decline of 87.3% in Q3 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | 1.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.46 Mn |
| Dec 31, 2025 | 1.20 Mn |
| Sep 30, 2025 | 1.61 Mn |
| Jun 30, 2025 | 137,592.00 |
| Mar 31, 2025 | 124,993.00 |
| Dec 31, 2024 | 134,211.00 |
| Sep 30, 2024 | 239,030.00 |
| Jun 30, 2024 | 191,958.00 |
| Mar 31, 2024 | 231,195.00 |
| Dec 31, 2023 | 271,737.00 |
| Sep 30, 2023 | 365,544.00 |
| Jun 30, 2023 | 281,584.00 |
| Mar 31, 2023 | 232,703.00 |
| Dec 31, 2022 | 303,164.00 |
| Sep 30, 2022 | 312,024.00 |
| Jun 30, 2022 | 463,230.00 |
| Mar 31, 2022 | 158,336.00 |
| Dec 31, 2021 | 627,295.00 |
| Sep 30, 2021 | 188,833.00 |
| Jun 30, 2021 | 694,436.00 |
API Access
Oncotelic Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();